The Food and Drug Administration panel voted 13-10 that the antiviral drug's benefits outweigh its risks, including potential birth defects if used during pregnancy.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}